| Malignant Prostate Neoplasm predicts response to …PREDICTS_RESPONSE_TO27 of 27show fewer |
|---|
| in context · predicts response to | AR AR-V7splice → predicts response to Abiraterone 4 source records aggregated | resistance | B | Malignant Prostate Neoplasm | 4 | Curated | civic | graph → |
| in context · predicts response to | AR AR-V7splice → predicts response to Enzalutamide 4 source records aggregated | resistance | B | Malignant Prostate Neoplasm | 4 | Curated | civic | graph → |
| in context · predicts response to | MRE11 Frameshiftindel → predicts response to Olaparib | sensitivity | B | Malignant Prostate Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | DEFA1 EXPRESSIONexpression → predicts response to Docetaxel | sensitivity | B | Malignant Prostate Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | BRCA1 Mutationother → predicts response to Olaparib | sensitivity | B | Malignant Prostate Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | BRCA2 Mutationother → predicts response to Olaparib | sensitivity | B | Malignant Prostate Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | PTEN Deletiondeletion_cna → predicts response to Everolimus | sensitivity | B | Malignant Prostate Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | AR Mutationother → predicts response to Cyproterone Acetate | resistance | B | Malignant Prostate Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | AR Mutationother → predicts response to Nilutamide | resistance | B | Malignant Prostate Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | AR Mutationother → predicts response to Bicalutamide | resistance | B | Malignant Prostate Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | AR Mutationother → predicts response to Flutamide | resistance | B | Malignant Prostate Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | BRCA2 Loss-of-function → predicts response to Olaparib | sensitivity | B | Malignant Prostate Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | TYMS Underexpressionexpression → predicts response to Pemetrexed | sensitivity | C | Malignant Prostate Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | BRCA1 Loss-of-functionloss_of_heterozygosity → predicts response to Olaparib | sensitivity | C | Malignant Prostate Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | PALB2 Biallelic Inactivation → predicts response to Olaparib | sensitivity | C | Malignant Prostate Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ATM Mutationother → predicts response to Olaparib | sensitivity | C | Malignant Prostate Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ATM N2875HSNV → predicts response to Olaparib | sensitivity | C | Malignant Prostate Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ATM S2289*indel → predicts response to Olaparib | sensitivity | C | Malignant Prostate Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | STK11 Underexpressionexpression → predicts response to SB202190 | sensitivity | D | Malignant Prostate Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | GAS6 EXPRESSIONexpression → predicts response to Docetaxel | resistance | D | Malignant Prostate Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | CFLAR Overexpressionexpression → predicts response to Bicalutamide | resistance | D | Malignant Prostate Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | IGF2 Overexpressionexpression → predicts response to Cabazitaxel | sensitivity | D | Malignant Prostate Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | IGF2 Overexpressionexpression → predicts response to Linsitinib | sensitivity | D | Malignant Prostate Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | IGF2 Overexpressionexpression → predicts response to Docetaxel | sensitivity | D | Malignant Prostate Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | PTEN Lossdeletion_cna → predicts response to Temsirolimus | sensitivity | D | Malignant Prostate Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | AR F877LSNV → predicts response to Apalutamide | resistance | D | Malignant Prostate Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | AR F877LSNV → predicts response to Enzalutamide | resistance | D | Malignant Prostate Neoplasm | 1 | Curated | civic | graph → |